DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,015 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,235,559 | +1.3% | 40,967 | +1.2% | 1.76% | +0.6% |
Q1 2024 | $10,104,064 | +13.7% | 40,462 | +5.4% | 1.75% | +4.7% |
Q4 2023 | $8,885,154 | +4.9% | 38,407 | +12.5% | 1.67% | -7.4% |
Q3 2023 | $8,470,446 | +5.1% | 34,141 | +1.7% | 1.80% | +12.4% |
Q2 2023 | $8,060,689 | -1.1% | 33,586 | +3.9% | 1.60% | -4.8% |
Q1 2023 | $8,146,475 | -3.1% | 32,322 | +2.1% | 1.68% | -3.1% |
Q4 2022 | $8,403,755 | +40.5% | 31,662 | +36.7% | 1.74% | +29.5% |
Q3 2022 | $5,980,000 | +6.7% | 23,154 | +4.8% | 1.34% | +13.8% |
Q2 2022 | $5,603,000 | +6.2% | 22,102 | +22.9% | 1.18% | +15.5% |
Q1 2022 | $5,277,000 | +177.2% | 17,990 | +210.8% | 1.02% | +186.8% |
Q4 2021 | $1,904,000 | +12.3% | 5,788 | +3.9% | 0.36% | +3.5% |
Q3 2021 | $1,695,000 | +15.6% | 5,569 | +2.0% | 0.34% | +6.2% |
Q2 2021 | $1,466,000 | +28.3% | 5,462 | +7.6% | 0.32% | +15.3% |
Q1 2021 | $1,143,000 | +47.5% | 5,078 | +45.6% | 0.28% | +29.5% |
Q4 2020 | $775,000 | +16.5% | 3,487 | +12.9% | 0.22% | -5.2% |
Q3 2020 | $665,000 | +34.3% | 3,088 | +10.2% | 0.23% | +27.2% |
Q2 2020 | $495,000 | +43.5% | 2,802 | +12.3% | 0.18% | -49.2% |
Q1 2020 | $345,000 | +8.5% | 2,494 | +20.5% | 0.35% | +14.6% |
Q4 2019 | $318,000 | – | 2,070 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |